Evaluation of first-line and salvage therapies for unresectable malignant mesothelioma: A systematic review and network meta-analysis

May 7, 2024 | Comments Off on Evaluation of first-line and salvage therapies for unresectable malignant mesothelioma: A systematic review and network meta-analysis

Critical Reviews in Oncology and Hematology 2024 April 26 [Link] Wei Zhuang, Lihui Liu, Boyang Sun, Hua Bai, Zhijie Wang, Jianchun Duan, Rui Wan, Zixiao Ma, Jia Zhong, Jie Wang…

Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights

May 6, 2024 | Comments Off on Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights

Open Respiratory Archives 2024 April 5 [Link] Rafael López-Castro, Álvaro Fuentes-Martín, Andrea Medina Del Valle, Tania García Peña, José Soro García, Leticia López González, Ángel Cilleruelo Ramos Abstract MPM stands…

Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights

May 3, 2024 | Comments Off on Advances in Immunotherapy for Malignant Pleural Mesothelioma: From Emerging Strategies to Translational Insights

Open Respiratory Archives 2024 April 5 [Link] Rafael López-Castro, Álvaro Fuentes-Martín, Andrea Medina Del Valle, Tania García Peña, José Soro García, Leticia López González, Ángel Cilleruelo Ramos Abstract MPM stands…

Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice

May 2, 2024 | Comments Off on Genomic characterization and detection of potential therapeutic targets for peritoneal mesothelioma in current practice

Clinical and Experimental Medicine 2024 April 20 [Link] Job P van Kooten, Michelle V Dietz, Hendrikus Jan Dubbink, Cornelis Verhoef, Joachim G J V Aerts, Eva V E Madsen, Jan…

Risk factors influencing postoperative pleural empyema in patients with pleural mesothelioma: a retrospective single-centre analysis

May 1, 2024 | Comments Off on Risk factors influencing postoperative pleural empyema in patients with pleural mesothelioma: a retrospective single-centre analysis

European Journal of Cardiothoracic Surgery 2024 March 29 [Link] Peter Henschke, Laura Chiara Guglielmetti, Sven Hillinger, Gian-Marco Monsch, Didier Schneiter, Isabelle Opitz, Olivia Lauk Abstract Objectives: Postoperative empyema is a…

Diffuse pleural mesotheliomas with genomic near-haploidization: a newly recognized subset with distinct clinical, histologic, and molecular features

April 30, 2024 | Comments Off on Diffuse pleural mesotheliomas with genomic near-haploidization: a newly recognized subset with distinct clinical, histologic, and molecular features

Clinical Cancer Research 2024 April 7 [Link] Soo-Ryum Yang, Gowtham Jayakumaran, Jamal Benhamida, Christopher A Febres Aldana, Rachel Fanaroff, Jason Chang, Erika Gedvilaite, Liliana B Villafania, Jennifer L Sauter, Michael…

Circulating SMRP and CA-125 before and after pleurectomy decortication for pleural mesothelioma

April 29, 2024 | Comments Off on Circulating SMRP and CA-125 before and after pleurectomy decortication for pleural mesothelioma

Thoracic Cancer 2024 April 16 [Link] Juuso Paajanen, Ahmed Sadek, William G Richards, Yue Xie, Emanuele Mazzola, Kristina Sidopoulos, John Kuckelman, Ritu R Gill, Raphael Bueno Abstract Background: Tumor recurrence…

Development of Patient and Caregiver Conceptual Models Investigating the Health-Related Quality of Life Impacts of Malignant Pleural Mesothelioma

April 26, 2024 | Comments Off on Development of Patient and Caregiver Conceptual Models Investigating the Health-Related Quality of Life Impacts of Malignant Pleural Mesothelioma

The Patient 2024 April 15 [Link] Adam E J Gibson, Waqas Ahmed, Louise Longworth, Bryan Bennett, Melinda Daumont, Liz Darlison Abstract Background: Malignant pleural mesothelioma (MPM) is a rare and…

Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma

April 25, 2024 | Comments Off on Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma

Cancers 2024 March 22 [Link] Karen M Yun, Lyudmila Bazhenova Abstract Malignant pleural mesothelioma (MPM) is a heterogeneous cancer composed of distinct molecular and pathologic subtypes. Unfortunately, MPM is aggressive,…

High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma

April 24, 2024 | Comments Off on High mobility group box 1 mediates inflammatory responses in malignant peritoneal mesothelioma

International Immunopharmacology 2024 April 12 [Link] Lianfen Wang, Xuesong Wang, Ningning Sun, Weili Liu Abstract Background: Serum high mobility group box 1 (HMGB1) serves as a diagnostic biomarker for malignant…

Categories